Tower Research Capital (TRC)’s Renmin Tianli Group, Inc. Common Shares ABAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-252
Closed -$1K 4774
2019
Q1
$1K Buy
+252
New +$332 ﹤0.01% 3718
2017
Q2
Sell
-76
Closed 4043
2017
Q1
$0 Buy
+76
New +$234 ﹤0.01% 4643
2016
Q1
Sell
-70
Closed 5784
2015
Q4
$0 Sell
70
-98
-58% -$291 ﹤0.01% 5750
2015
Q3
$0 Sell
168
-275
-62% -$1K ﹤0.01% 5653
2015
Q2
$2K Sell
443
-213
-32% -$1.36K ﹤0.01% 3914
2015
Q1
$4K Buy
656
+79
+14% +$494 ﹤0.01% 3510
2014
Q4
$4K Sell
577
-71
-11% -$594 ﹤0.01% 3039
2014
Q3
$5K Buy
+648
New +$4.83K ﹤0.01% 3388

Tower Research Capital (TRC)'s ABAC Position: Q2 2019 in Review

Tower Research Capital (TRC) sold out of Renmin Tianli Group, Inc. Common Shares (ABAC) in Q2 2019, closing a stake of 252 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in ABAC in Q3 2014 and held it in 8 quarters. The position peaked at $5K in Q3 2014. 0 funds tracked by Wall St. Rank hold ABAC as of Q2 2019.

  • Tower Research Capital (TRC) reported no remaining Renmin Tianli Group, Inc. Common Shares position as of Q2 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 252 Renmin Tianli Group, Inc. Common Shares shares in Q2 2019, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Renmin Tianli Group, Inc. Common Shares in Q3 2014 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Renmin Tianli Group, Inc. Common Shares position peaked at $5K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Renmin Tianli Group, Inc. Common Shares as of Q2 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.